KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 113 filers reported holding KRYSTAL BIOTECH INC in Q2 2020. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,423,972 | -17.1% | 29,517 | -16.1% | 0.93% | -23.7% |
| Q2 2023 | $4,128,958 | +141.2% | 35,170 | +62.8% | 1.21% | +174.4% |
| Q4 2022 | $1,711,548 | +13.6% | 21,605 | 0.0% | 0.44% | +10.5% |
| Q3 2022 | $1,506,000 | +6.1% | 21,605 | 0.0% | 0.40% | +14.9% |
| Q2 2022 | $1,419,000 | -2.9% | 21,605 | -1.6% | 0.35% | +29.4% |
| Q1 2022 | $1,461,000 | -4.9% | 21,959 | 0.0% | 0.27% | -1.5% |
| Q4 2021 | $1,536,000 | +18.2% | 21,959 | -27.0% | 0.27% | -64.1% |
| Q1 2020 | $1,300,000 | -21.9% | 30,065 | -0.0% | 0.76% | +14.1% |
| Q4 2019 | $1,665,000 | +16.0% | 30,070 | -27.2% | 0.67% | -4.6% |
| Q3 2019 | $1,435,000 | +7.6% | 41,329 | +24.7% | 0.70% | +23.1% |
| Q2 2019 | $1,334,000 | – | 33,137 | – | 0.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 1,913,280 | $153,177,197 | 6.65% |
| Frazier Life Sciences Management, L.P. | 945,407 | $75,689,284 | 5.48% |
| S Squared Technology, LLC | 108,215 | $8,663,693 | 5.14% |
| Nicholas Investment Partners, LP | 374,718 | $29,999,923 | 2.28% |
| Avoro Capital Advisors LLC | 1,750,000 | $140,105,000 | 2.08% |
| Artal Group S.A. | 412,082 | $32,991 | 1.96% |
| First Light Asset Management, LLC | 195,980 | $15,690,159 | 1.41% |
| Integral Health Asset Management, LLC | 85,000 | $6,805,100 | 1.37% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 61,000 | $4,883,660 | 1.36% |
| Hood River Capital Management LLC | 447,393 | $35,818,000 | 1.16% |